Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of Matthew LeClair as Senior Vice President (SVP) and Site Head of its San Diego Operations.
With more than 29 years’ experience in the biopharmaceutical industry, Matt has previously held roles at Takeda, including Site Head in Singapore and Site Head of the Milford, Massachusetts facility. Prior to joining Takeda, Matthew was at Stryker Biotech.
Matthew brings with him extensive experience of multiple technology transfers, developing site expansion plans, and ensuring start-up and licensure of manufacturing suites. He has also previously achieved manufacturing success through the deployment of several operational excellence initiatives.
Before entering the health care industry, he was in the United States Navy as an Aviation Electricians Mate 2nd Class. He received his Bachelor of Science in Business Administration at Colorado Technical University in Colorado Springs, Colorado.
About Abzena
Abzena is a leading partner research organization which offers discovery, design, development and cGMP manufacture of biologics, bioconjugates and complex or highly potent small molecules to the global biopharmaceutical industry. From its facilities in the UK and US the company provides its customers with concept to clinic solutions. Abzena is owned by Welsh, Carson, Anderson & Stowe, one of the world’s leading private equity investors.
